Finance

Lists
1783:TPE
Maxigen Biotech Inc
NT$36.90
-0.40%
(-0.15) 1D
Oct 5, 1:30:06 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1783...
Open
NT$37.05
High
NT$37.15
Low
NT$36.70
Mkt. cap
3.31B
Avg. vol.
60.62K
Volume
32.75K
Dividend
5.42%
Quarterly dividend
NT$0.50
Ex-dividend date
Sep 1, 2026
P/E ratio
11.42
52-wk high
NT$48.30
52-wk low
NT$33.05
EPS
NT$3.23
Shares outstanding
77.46M
No. of employees
96
Open
NT$37.05
High
NT$37.15
Low
NT$36.70
Mkt. cap
3.31B
Avg. vol.
60.62K
Volume
32.75K
Dividend
5.42%
Quarterly dividend
NT$0.50
Ex-dividend date
Sep 1, 2026
P/E ratio
11.42
52-wk high
NT$48.30
52-wk low
NT$33.05
EPS
NT$3.23
Shares outstanding
77.46M
No. of employees
96
News stories
From web sources and news partners
About Maxigen Biotech Inc
CEO-
Employees96
Founded1998
Headquarters-
SectorBiotechnology
Websitembi-bio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
200.86M
224.71M
190.87M
221.01M
Cost of goods sold
65.82M
59.43M
56.31M
70.46M
Cost of revenue
65.82M
59.43M
56.31M
70.46M
Research and development expenses
33.17M
33.88M
35.38M
48.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45.82M
41.88M
40.77M
44.85M
Operating expense
81.90M
78.78M
76.15M
93.78M
Total operating expenses
147.72M
138.21M
132.46M
164.24M
Operating income
53.14M
86.50M
58.41M
56.78M
Other non operating income
155.00K
3.28M
2.69M
2.30M
EBT including unusual items
89.48M
102.44M
68.65M
64.35M
EBT excluding unusual items
89.48M
102.44M
68.65M
64.35M
Income tax expense
13.95M
18.70M
15.86M
-14.78M
Effective tax rate
15.59%
18.26%
23.10%
-22.98%
Other operating expenses
-
-
-
-
Net income
75.54M
83.74M
52.79M
79.13M
Net profit margin
37.61%
37.27%
27.66%
35.80%
Earnings per share
-
-
-
-
Interest and investment income
27.65M
3.07M
2.55M
3.80M
Interest expense
-
-43.00K
-61.00K
-96.00K
Net interest expenses
27.65M
3.03M
2.48M
3.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
61.17M
95.81M
67.77M
66.42M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps